Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAPTHEALTH CORP.

(AHCO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

AdaptHealth Corp. Announces Appointment of Greg Belinfanti as Director

09/30/2021 | 06:30am EST

AdaptHealth Corp. announced that Greg Belinfanti was appointed to the Company’s Board of Directors. Mr. Belinfanti is a Senior Managing Director of One Equity Partners and will serve as OEP’s designee on the Board of Directors. Mr. Belinfanti currently sits on the boards of Restorix Health and Ernest Health, and was also formerly a board member of Simplura Health Group, Arthrocare Inc, and Celltrion Healthcare, a publicly listed company in Korea. Brad Coppens, previously appointed as OEP’s designated member of the Board of Directors, will continue to serve as an independent director.


© S&P Capital IQ 2021
All news about ADAPTHEALTH CORP.
11/19AdaptHealth Corp. Announces Resignation of Frank Mullen as Chief Accounting Officer, Ef..
CI
11/04AdaptHealth Swings to Profit in Q3, Revenue Climbs; Raises 2021 Revenue Guidance, Provi..
MT
11/04AdaptHealth to Seek Acquisitions
CI
11/04ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS, RAISES FULL-YEAR 2021 GUIDA..
PU
11/04AdaptHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
CI
11/04AdaptHealth Corp. Announces Third Quarter 2021 Financial Results
PU
11/04Earnings Flash (AHCO) ADAPTHEALTH Posts Q3 Revenue $653.3M, vs. Street Est of $638.7M
MT
11/04AeroCare Holdings, Inc. Provides Earnings Guidance for the Year 2021
CI
11/04AdaptHealth Corp. Revises Earnings Guidance for the Year 2021
CI
10/04ADAPTHEALTH : ANNOUNCES APPOINTMENT OF GREG BELINFANTI AS DIRECTOR (Form 8-K)
PU
More news
Financials (USD)
Sales 2021 2 441 M - -
Net income 2021 147 M - -
Net Debt 2021 1 839 M - -
P/E ratio 2021 20,1x
Yield 2021 -
Capitalization 2 936 M 2 936 M -
EV / Sales 2021 1,96x
EV / Sales 2022 1,65x
Nbr of Employees 4 700
Free-Float 62,1%
Chart ADAPTHEALTH CORP.
Duration : Period :
AdaptHealth Corp. Technical Analysis Chart | AHCO | US00653Q1022 | MarketScreener
Technical analysis trends ADAPTHEALTH CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 22,21 $
Average target price 37,90 $
Spread / Average Target 70,6%
EPS Revisions
Managers and Directors
Stephen P. Griggs Chief Executive Officer & Director
Joshua Parnes President & Director
Jason A. Clemens Chief Financial Officer
Richard A. Barasch Chairman
Albert A. Prast Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ADAPTHEALTH CORP.-40.87%2 936
ABBOTT LABORATORIES20.90%234 068
MEDTRONIC PLC-4.16%151 155
BECTON, DICKINSON AND COMPANY-1.51%69 998
HOYA CORPORATION29.61%59 943
DEXCOM, INC.52.78%54 746